Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals
Neurological complications associated with the human immunodeficiency virus (HIV) are a matter of great concern. While antiretroviral (ARV) drugs are the cornerstone of HIV treatment and typically produce neurological benefit, some ARV drugs have limited CNS penetration while others have been associ...
Saved in:
Main Authors: | Jacinta Nwamaka Nwogu, Qing Ma, Chinedum Peace Babalola, Waheed Adeola Adedeji, Gene D. Morse, Babafemi Taiwo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | AIDS Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2016/2587094 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics of Oral Antidiabetic Drugs
by: Matthijs L. Becker, et al.
Published: (2013-01-01) -
Pharmacogenetics of Chronic Pain and Its Treatment
by: Svatopluk Světlík, et al.
Published: (2013-01-01) -
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
by: Amilton Dos Santos-Júnior, et al.
Published: (2016-01-01) -
The Impact of Herbal Drug Use on Adverse Drug Reaction Profiles of Patients on Antiretroviral Therapy in Zimbabwe
by: Tinashe Mudzviti, et al.
Published: (2012-01-01) -
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Arwa M. Amin, et al.
Published: (2017-01-01)